GDC-0349

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDC-0349, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma [Phase 1]

See pricing